Psychopharmacology

Psychotic Disorders

Tardive Dyskinesia 360°

Thursday, October 25
12:00 PM - 2:00 PM
Location: Valencia W415 A-D

Lunch will be served. Seating for this sessions is available on a first-come, first served basis. Please plan to arrive early to ensure a seat. Lunch will only be available until 12:30 P.M.

Tardive dyskinesia (TD), a syndrome characterized by hyperkinetic and abnormal involuntary movements, imposes devastating effects on a patient’s quality of life and negatively impacts daily function and social well-being. Symptoms are rarely reversible, with a cumulative risk incurred by the extent of antipsychotic treatment duration. This session brings together a psychiatrist and a neurologist to discuss the challenges of diagnosing and treating patients with TD. These experts will review the latest data on current and recently approved treatments for TD and demonstrate how to incorporate that information into everyday clinical practice through an interactive, live-patient case presentation.

Supported by an educational grant from Neurocrine Biosciences and Teva Pharmaceuticals.

Rakesh Jain, MD

Clinical Professor
Texas Tech
Texas Tech University School of Medicine - Permian Bason
Austin, Texas

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on impact of substance abuse. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training, by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute, in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

Presentation(s):

Send Email for Rakesh Jain

Rajeev Kumar, MD

Director
Rocky Mountain Movement Disorders Center, Huntington's Disease Society of America Center of Excellence, Colorado Neurological Institute, Englewood, Colorado

Rajeev Kumar, MD, FRCPC, is the Medical Director of the Rocky Mountain Movement Disorders Center and the HDSA Center of Excellence and NPF Care Center at the Colorado Neurological Institute. Dr. Kumar is a movement disorders neurologist who attended medical school at the University of Saskatchewan in Canada, completed his residency at Mayo Clinic, and fellowship at the University of Toronto. He has published extensively on various movement disorders including the use botulinum toxin for dystonia and deep brain stimulation to treat various movement disorders including Parkinson’s disease and dystonia. He is extensively involved in conducting clinical trials in Parkinson’s disease and Huntington’s disease. His clinical practice spans the gamut of movement disorders, including Huntington's disease, Parkinson's disease, dystonia, tremors, Tourette’s syndrome, spasticity, and restless legs syndrome.

Presentation(s):

Send Email for Rajeev Kumar


Assets

Tardive Dyskinesia 360°



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Tardive Dyskinesia 360°